Wako Masanori, Haro Hirotaka, Ando Takashi, Hatsushika Kyosuke, Ohba Tetsuro, Iwabuchi Sadahiro, Nakao Atsuhito, Hamada Yoshiki
Department of Orthopaedic Surgery, Graduate School of Medicine and Engineering, University of Yamanashi.
J Orthop Res. 2007 Nov;25(11):1438-46. doi: 10.1002/jor.20445.
The goal of this research was to examine the role of TWEAK in normal disc cells and to investigate its potential role in disc degeneration. We performed histological examinations of disc tissues and assessed the role of the novel cytokine TWEAK using murine organ disc culture. The expression of both TWEAK and its receptor, Fn14, in discs was confirmed by immunohistochemistry and quantitative real-time PCR. TWEAK induced disc cells to generate MMP-3 in a dose- and time-dependent manner. This induction was strongly inhibited in the presence of a neutralizing antibody to TWEAK or a chimeric Fn14/Fc fusion protein. In disc tissues derived from TNF-alpha receptor 1- or TNF-alpha receptor 2-deficient mice, recombinant TWEAK modestly induced MMP-3. In contrast, in disc cultures lacking TWEAK, tissues from wild-type mice or receptor-deficient mice failed to express MMP-3. Furthermore, aggrecan expression was potently abrogated in a time-dependent manner in the presence of recombinant TWEAK. This is the first report to confirm expression of TWEAK and its receptor Fn14 in murine intervertebral disc tissues. The data suggest that TWEAK plays a role in MMP-3 up-regulation and aggrecan down-regulation in disc tissues, resulting in proteoglycan degradation and promotion of disc degeneration.
本研究的目的是检测TWEAK在正常椎间盘细胞中的作用,并探究其在椎间盘退变中的潜在作用。我们对椎间盘组织进行了组织学检查,并使用小鼠器官椎间盘培养评估了新型细胞因子TWEAK的作用。通过免疫组织化学和定量实时PCR证实了TWEAK及其受体Fn14在椎间盘中的表达。TWEAK以剂量和时间依赖性方式诱导椎间盘细胞产生MMP-3。在存在TWEAK中和抗体或嵌合Fn14/Fc融合蛋白的情况下,这种诱导作用受到强烈抑制。在源自肿瘤坏死因子-α受体1或肿瘤坏死因子-α受体2缺陷小鼠的椎间盘组织中,重组TWEAK适度诱导MMP-3。相比之下,在缺乏TWEAK的椎间盘培养物中,野生型小鼠或受体缺陷小鼠的组织未能表达MMP-3。此外,在存在重组TWEAK的情况下,聚集蛋白聚糖的表达以时间依赖性方式被有效消除。这是首次证实TWEAK及其受体Fn14在小鼠椎间盘组织中表达的报告。数据表明,TWEAK在椎间盘组织中MMP-3上调和聚集蛋白聚糖下调中起作用,导致蛋白聚糖降解并促进椎间盘退变。